Previously we have shown that lung cancer contains a population of CD133+ cancer initiating cells, within which is a subpopulation of CD133+CXCR4+ EpCAM− cells that show an increased metastasis formation capability and could represent these clinically important lung MCICs (manuscript in preparation). This evidence concerns the gene PROM1 and lung cancer.